These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25362075)

  • 1. Evaluation of vancomycin dosing and corresponding drug concentrations in pediatric patients.
    Geerlof LM; Boucher J
    Hosp Pediatr; 2014 Nov; 4(6):342-7. PubMed ID: 25362075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations.
    Frymoyer A; Guglielmo BJ; Wilson SD; Scarpace SB; Benet LZ; Hersh AL
    Pharmacotherapy; 2011 Sep; 31(9):871-6. PubMed ID: 21923588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empirical Vancomycin Dosing in Pediatric Patients with Congenital Heart Disease and the Impact of Cardiopulmonary Bypass on Trough Concentrations.
    Thomas CA; Picone A; Menon S; Willis BC
    Pharmacotherapy; 2017 Nov; 37(11):1341-1346. PubMed ID: 28833385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.
    Finch NA; Zasowski EJ; Murray KP; Mynatt RP; Zhao JJ; Yost R; Pogue JM; Rybak MJ
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Initial Vancomycin Trough Concentration on Clinical and Microbiological Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.
    Yoo RN; Kim SH; Lee J
    J Korean Med Sci; 2017 Jan; 32(1):22-28. PubMed ID: 27914127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome.
    McNeil JC; Kok EY; Forbes AR; Lamberth L; Hulten KG; Vallejo JG; Mason EO; Kaplan SL
    Pediatr Infect Dis J; 2016 Mar; 35(3):263-8. PubMed ID: 26646549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Safety of a Vancomycin Nomogram Used to Achieve Target Trough Concentrations.
    O'Brien KA; Mok S
    Hosp Pharm; 2015 Nov; 50(10):900-910. PubMed ID: 27729678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
    Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of vancomycin dosing for complicated infections in pediatric patients.
    Durham SH; Simmons ML; Mulherin DW; Foland JA
    Hosp Pediatr; 2015 May; 5(5):276-81. PubMed ID: 25934812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of age and weight on vancomycin serum trough concentrations in pediatric patients.
    Madigan T; Sieve RM; Graner KK; Banerjee R
    Pharmacotherapy; 2013 Dec; 33(12):1264-72. PubMed ID: 23864541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort.
    Kullar R; Davis SL; Taylor TN; Kaye KS; Rybak MJ
    Pharmacotherapy; 2012 Mar; 32(3):195-201. PubMed ID: 22392452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin dosing and target attainment in children.
    Hwang D; Chiu NC; Chang L; Peng CC; Huang DT; Huang FY; Chi H
    J Microbiol Immunol Infect; 2017 Aug; 50(4):494-499. PubMed ID: 26462708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin AUC/MIC and Corresponding Troughs in a Pediatric Population.
    Kishk OA; Lardieri AB; Heil EL; Morgan JA
    J Pediatr Pharmacol Ther; 2017; 22(1):41-47. PubMed ID: 28337080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
    Ploessl C; White C; Manasco K
    Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Body Surface Area for Dosing of Vancomycin.
    Sawrey EL; Subramanian MW; Ramirez KA; Snyder BS; Logston BB; Russell GB
    J Pediatr Pharmacol Ther; 2019; 24(4):296-303. PubMed ID: 31337992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection?
    Hale CM; Seabury RW; Steele JM; Darko W; Miller CD
    J Pharm Pract; 2017 Jun; 30(3):329-335. PubMed ID: 27074786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allometric versus consensus guideline dosing in achieving target vancomycin trough concentrations.
    Brown ML; Hutchison AM; McAtee AM; Gaillard PR; Childress DT
    Am J Health Syst Pharm; 2017 Jul; 74(14):1067-1075. PubMed ID: 28522643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Individual Pharmacokinetics to Improve Time to Therapeutic Vancomycin Trough in Pediatric Oncology Patients.
    Miller CL; Winans SA; Veillette JJ; Forland SC
    J Pediatr Pharmacol Ther; 2018; 23(2):92-99. PubMed ID: 29720909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a vancomycin dosing nomogram in achieving high target trough concentrations in Taiwanese patients.
    Leu WJ; Liu YC; Wang HW; Chien HY; Liu HP; Lin YM
    Int J Infect Dis; 2012 Nov; 16(11):e804-10. PubMed ID: 22917921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.